0001179110-15-008909.txt : 20150602
0001179110-15-008909.hdr.sgml : 20150602
20150602170730
ACCESSION NUMBER: 0001179110-15-008909
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150529
FILED AS OF DATE: 20150602
DATE AS OF CHANGE: 20150602
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALERE INC.
CENTRAL INDEX KEY: 0001145460
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 043565120
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7816473900
MAIL ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: INVERNESS MEDICAL INNOVATIONS INC
DATE OF NAME CHANGE: 20010720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRIDGEN JOHN
CENTRAL INDEX KEY: 0001272539
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16789
FILM NUMBER: 15907715
MAIL ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: C/O INVERNESS MEDICAL INNOVATIONS INC
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
edgar.xml
FORM 4 -
X0306
4
2015-05-29
0
0001145460
ALERE INC.
ALR
0001272539
BRIDGEN JOHN
51 SAWYER ROAD, SUITE 200
WALTHAM
MA
02453
0
1
0
0
Sr VP, Business Develop
Common Stock
2015-05-29
4
M
0
22564
35.58
A
27116
D
Common Stock
2015-05-29
4
S
0
22564
51.165
D
4552
D
Employee Stock Option (Right to Buy)
35.58
2015-05-29
4
M
0
22564
D
2019-06-30
Common Stock
22564
0
D
Represents same day exercise and sale of stock options.
Option vested in four equal annual installments on 6/30/10, 6/30/11, 6/30/12 and 6/30/13.
This derivative security does not have a price.
The price reported is a weighted average price. These shares were sold in approximately 122 separate transactions at prices ranging from $51.00 to $51.385, inclusive. The reporting person hereby undertakes to provide to the SEC, the issuer or any stockholder of the issuer, upon request, the full information regarding the number of shares and prices at which the transaction was affected.
/s/ Jay McNamara, Attorney-in-Fact
2015-06-02